argenx
A Principal Scientist Bioanalytics at argenx leads bioanalytical strategies for clinical drug development of large molecules, ensuring alignment with global regulatory expectations and driving bioanalytical contributions to regulatory submissions.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
15% below the average for this role
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Senior Scientist, Bioanalytics
Sutro Biopharma
Associate Director, Bioanalytics
Latigobio
Senior Scientist, Bioanalytical and Biomarker Sciences
City Therapeutics
SENIOR SCIENTIST, BIOANALYTICS
Sutro Biopharma
Principal Scientist - US, Lenexa, Kansas (KS) - LBA Method Development Team
ICON plc
Sr. Principal Scientist / Director, DMPK & Bioanalytical Sciences
Alltrna